Screening of the Ethnobotanicals against MDA-MB-231 and MCF-7 breast cancer cell lines

Authors

  • Mohammed Shafi Sofi Molecular Diagnostics and Nanobiotechnology Laboratories, Department of Microbiology and Biotechnology, Bangalore University, J.B. Campus, Bangalore, Karnataka
  • M K Sateesh Molecular Diagnostics and Nanobiotechnology Laboratories, Department of Microbiology and Biotechnology, Bangalore University, J.B. Campus, Bangalore, Karnataka
  • Mohsin Bashir Molecular Reproduction and Developmental Genetics Laboratory. Indian Institute of Science, Bangalore, Karnataka

DOI:

https://doi.org/10.7439/ijpp.v4i6.123

Abstract

The present study aims to investigate the therapeutic properties of a library of the medicinal plants for their potential anticancer activity against breast cancer cells. The viability of MDA-MB-231 and MCF-7 breast cancer cells was determined by MTT and trypan blue exclusion assays. The cellular cytotoxicity and the levels of cytosolic enzyme Lactate Dehydrogenase (LDH) were measured by assessing moles of NADH/well/min. Additionally DNA laddering and FACS analysis was done to further investigate the nature of cell death in these cells. Out of the tested plants, only Abrus precatorius L. extract showed a very significant cytotoxic activity on both cell lines. Trypan-blue assay showed the cell viability was significantly decreased in a dose dependant manner in both cell lines after 48 h of treatment. On the other hand, LDH activities in the cultured media were significantly elevated in both cell lines in a dose dependant manner as compared to the control. A prominent DNA laddering pattern in agarose gel was seen, which is an important hallmark of apoptosis. FACS analysis confirmed the apoptosis by the appearance of Sub G0/G1 peak in treated cells as compared to the control. This analysis will facilitate the use of traditional medicine in cancer treatment.

Downloads

Downloads

Published

2014-12-30

Issue

Vol. 4 No. 6 (2014): Nov-Dec

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Screening of the Ethnobotanicals against MDA-MB-231 and MCF-7 breast cancer cell lines. Int J of Phytopharm [Internet]. 2014 Dec. 30 [cited 2025 Mar. 15];4(6):140-7. Available from: https://ssjournals.co.in/index.php/ijpp/article/view/1473